Please use this identifier to cite or link to this item:
|Title:||Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO).|
Central Nervous System Neoplasms
Combined Modality Therapy
Lymphoma, Large B-Cell, Diffuse
|Abstract:||Diffuse large B-cell lymphoma patients have a 5% overall risk of central nervous system events (relapse or progression), which account for high morbidity and frequently fatal outcomes,1 and shortened overall survival of <6 months.2 Early diagnosis of central nervous system events is critical for successful treatment and improved prognosis. Identification of patients at risk of central nervous system disease is critical to accurately identify candidates for central nervous system prophylaxis vs.|
|Appears in Collections:||Hospitales > H. U. Fundación Alcorcón > Artículos|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.